When Should You Buy Ekso Bionics Holdings Inc (NASDAQ:EKSO)?
Ekso Bionics Holdings Inc (NASDAQ:EKSO), a medical equipment company based in United States, led the NasdaqCM gainers with a relatively large price hike in the past couple of weeks. As a small cap stock, hardly covered by any analysts, there is generally more of an opportunity for mispricing as there is less activity to push the stock closer to fair value. Is there still an opportunity here to buy? Let’s examine Ekso Bionics Holdings’s valuation and outlook in more detail to determine if there’s still a bargain opportunity. Check out our latest analysis for Ekso Bionics Holdings
Is Ekso Bionics Holdings still cheap?
According to my relative valuation model, the stock seems to be currently fairly priced. In this instance, I’ve used the price-to-book (PB) ratio given that there is not enough information to reliably forecast the stock’s cash flows, and its earnings doesn’t seem to reflect its true value. I find that Ekso Bionics Holdings’s ratio of 4.43x is trading slightly above its industry peers’ ratio of 3.78x, which means if you buy Ekso Bionics Holdings today, you’d be paying a relatively reasonable price for it. And if you believe that Ekso Bionics Holdings should be trading at this level in the long run, there’s only an insignificant downside when the price falls to its real value. So, is there another chance to buy low in the future? Given that Ekso Bionics Holdings’s share is fairly volatile (i.e. its price movements are magnified relative to the rest of the market) this could mean the price can sink lower, giving us an opportunity to buy later on. This is based on its high beta, which is a good indicator for share price volatility.
What does the future of Ekso Bionics Holdings look like?
Future outlook is an important aspect when you’re looking at buying a stock, especially if you are an investor looking for growth in your portfolio. Buying a great company with a robust outlook at a cheap price is always a good investment, so let’s also take a look at the company’s future expectations. Ekso Bionics Holdings’s earnings over the next few years are expected to increase by 38.77%, indicating a highly optimistic future ahead. This should lead to more robust cash flows, feeding into a higher share value.
What this means for you:
Are you a shareholder? EKSO’s optimistic future growth appears to have been factored into the current share price, with shares trading around its fair value. However, there are also other important factors which we haven’t considered today, such as the financial strength of the company. Have these factors changed since the last time you looked at EKSO? Will you have enough confidence to invest in the company should the price drop below its fair value?
Are you a potential investor? If you’ve been keeping tabs on EKSO, now may not be the most advantageous time to buy, given it is trading around its fair value. However, the positive outlook is encouraging for EKSO, which means it’s worth diving deeper into other factors such as the strength of its balance sheet, in order to take advantage of the next price drop.
Price is just the tip of the iceberg. Dig deeper into what truly matters – the fundamentals – before you make a decision on Ekso Bionics Holdings. You can find everything you need to know about Ekso Bionics Holdings in the latest infographic research report. If you are no longer interested in Ekso Bionics Holdings, you can use our free platform to see my list of over 50 other stocks with a high growth potential.
To help readers see pass the short term volatility of the financial market, we aim to bring you a long-term focused research analysis purely driven by fundamental data. Note that our analysis does not factor in the latest price sensitive company announcements.
The author is an independent contributor and at the time of publication had no position in the stocks mentioned.
